Your browser is no longer supported. Please, upgrade your browser.
Settings
CFX [NYSE]
Colfax Corporation
Index- P/E59.39 EPS (ttm)0.78 Insider Own1.30% Shs Outstand159.09M Perf Week-8.49%
Market Cap7.26B Forward P/E18.08 EPS next Y2.57 Insider Trans-15.53% Shs Float137.44M Perf Month-10.03%
Income117.80M PEG2.25 EPS next Q0.80 Inst Own97.10% Short Float11.69% Perf Quarter-3.59%
Sales3.66B P/S1.98 EPS this Y532.80% Inst Trans5.90% Short Ratio13.73 Perf Half Y2.68%
Book/sh28.83 P/B1.61 EPS next Y20.44% ROA1.40% Target Price56.47 Perf Year28.71%
Cash/sh1.14 P/C40.91 EPS next 5Y26.34% ROE2.60% 52W Range34.94 - 54.67 Perf YTD21.44%
Dividend- P/FCF25.76 EPS past 5Y-20.90% ROI2.80% 52W High-15.05% Beta2.16
Dividend %- Quick Ratio1.00 Sales past 5Y-2.20% Gross Margin42.50% 52W Low32.91% ATR1.19
Employees15400 Current Ratio1.80 Sales Q/Q19.90% Oper. Margin6.60% RSI (14)25.14 Volatility2.56% 2.24%
OptionableYes Debt/Eq0.35 EPS Q/Q44.70% Profit Margin2.90% Rel Volume1.85 Prev Close48.17
ShortableYes LT Debt/Eq0.35 EarningsNov 04 BMO Payout0.00% Avg Volume1.17M Price46.44
Recom2.10 SMA20-9.60% SMA50-6.36% SMA200-0.24% Volume2,164,388 Change-3.59%
Sep-10-21Downgrade Goldman Buy → Neutral $53 → $51
Apr-06-21Downgrade Barclays Equal Weight → Underweight $48 → $45
Nov-09-20Upgrade UBS Neutral → Buy $36 → $40
Sep-16-20Initiated UBS Neutral $36
May-29-20Initiated JP Morgan Overweight $32
May-11-20Upgrade Northcoast Neutral → Buy $38
Jan-16-20Resumed Goldman Buy $44
Dec-17-19Upgrade BofA/Merrill Neutral → Buy
Nov-27-19Resumed Barclays Equal Weight $36
Nov-04-19Upgrade BofA/Merrill Underperform → Neutral $27 → $37
Apr-05-19Resumed Goldman Buy
Sep-04-18Upgrade Oppenheimer Perform → Outperform
Aug-21-18Initiated Morgan Stanley Equal-Weight $34
Jun-04-18Downgrade BofA/Merrill Buy → Underperform
May-04-18Downgrade RBC Capital Mkts Outperform → Sector Perform
Feb-15-18Initiated Barclays Underweight $29
Feb-07-18Upgrade Gabelli & Co Hold → Buy
Feb-07-18Reiterated Stifel Buy $48 → $40
Jan-16-18Reiterated Stifel Buy $44 → $48
Nov-21-17Upgrade Longbow Neutral → Buy
Nov-25-21 06:28AM  
Nov-11-21 11:24AM  
Nov-05-21 12:14PM  
Nov-04-21 02:31PM  
10:30AM  
08:03AM  
07:35AM  
06:00AM  
Nov-01-21 12:18PM  
Oct-28-21 03:05PM  
Oct-18-21 10:45AM  
10:20AM  
Oct-07-21 06:53AM  
Oct-06-21 10:36AM  
09:42AM  
Oct-04-21 01:06PM  
Sep-22-21 07:00AM  
Sep-10-21 08:57AM  
Sep-07-21 07:00AM  
Aug-31-21 07:00AM  
Aug-27-21 11:31AM  
Aug-19-21 10:08AM  
Aug-08-21 03:16AM  
Jul-30-21 11:40AM  
09:51AM  
Jul-29-21 02:30PM  
Jul-28-21 10:14PM  
06:45PM  
04:31PM  
04:26PM  
04:14PM  
12:10PM  
Jul-26-21 10:40AM  
10:08AM  
Jul-24-21 04:08AM  
Jul-22-21 03:03PM  
Jul-14-21 05:36PM  
11:40AM  
08:27AM  
Jun-21-21 01:11PM  
Jun-18-21 02:01AM  
May-18-21 12:37PM  
May-13-21 03:04AM  
Apr-30-21 11:55AM  
Apr-29-21 06:00AM  
05:45AM  
Apr-27-21 12:10PM  
Apr-26-21 07:00AM  
Apr-22-21 12:33PM  
Apr-14-21 01:07PM  
Apr-12-21 03:51PM  
Apr-07-21 03:01AM  
Mar-30-21 07:00AM  
Mar-26-21 09:36AM  
Mar-25-21 06:00AM  
Mar-16-21 11:30PM  
12:54PM  
Mar-15-21 04:05PM  
Mar-08-21 01:52PM  
Mar-05-21 06:52AM  
Mar-04-21 06:41AM  
06:35AM  
06:00AM  
Feb-22-21 04:45PM  
Feb-21-21 02:04AM  
Feb-18-21 01:30PM  
07:46AM  
06:15AM  
06:00AM  
Jan-29-21 01:40PM  
Jan-21-21 09:24AM  
Jan-19-21 07:00PM  
Jan-13-21 09:38AM  
Jan-08-21 02:14PM  
Jan-06-21 01:13AM  
Dec-14-20 02:38PM  
09:09AM  
Dec-11-20 08:00AM  
Nov-27-20 10:02AM  
Nov-24-20 02:25PM  
Nov-13-20 09:24AM  
Nov-12-20 08:00AM  
Nov-07-20 08:43AM  
Nov-03-20 01:16PM  
Oct-30-20 11:58AM  
Oct-29-20 07:30AM  
06:00AM  
06:00AM  
Oct-22-20 12:34PM  
Oct-17-20 07:12AM  
Oct-14-20 09:13AM  
Oct-12-20 09:55AM  
Oct-09-20 09:00AM  
Sep-30-20 09:29AM  
Sep-25-20 02:11PM  
Sep-11-20 08:04AM  
Sep-08-20 08:11PM  
Sep-05-20 11:31AM  
Aug-20-20 07:00AM  
Aug-10-20 10:01AM  
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is based in Wilmington, Delaware.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRYOR DANIEL AEVP, Strategy & Business Dev.Nov 08Option Exercise52.0255628,923164,813Nov 10 06:59 PM
Trerotola Matthew L.President & CEONov 08Option Exercise39.5450,0001,977,000355,708Nov 10 07:01 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Nov 08Sale53.0355629,486164,257Nov 10 06:59 PM
Trerotola Matthew L.President & CEONov 08Sale53.0250,0002,651,038305,708Nov 10 07:01 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Nov 05Option Exercise52.027,289379,174171,546Nov 08 06:00 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Nov 05Sale54.107,289394,313164,257Nov 08 06:00 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Nov 04Option Exercise52.0216,616864,364180,873Nov 08 06:00 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Nov 04Sale53.9916,616897,075164,257Nov 08 06:00 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Nov 02Option Exercise52.026,340329,807170,597Nov 04 06:00 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Nov 02Sale53.026,340336,153164,257Nov 04 06:00 PM
Trerotola Matthew L.President & CEOOct 15Option Exercise39.5450,0001,977,000355,708Oct 19 06:00 PM
Kambeyanda ShyamESAB President and EVP, ColfaxOct 15Option Exercise24.9624,644615,114117,189Oct 19 06:00 PM
Kambeyanda ShyamESAB President and EVP, ColfaxOct 15Sale50.6939,8622,020,52377,327Oct 19 06:00 PM
Trerotola Matthew L.President & CEOOct 15Sale50.6850,0002,533,893305,708Oct 19 06:00 PM
Trerotola Matthew L.President & CEOSep 13Option Exercise23.7459,5631,414,026365,271Sep 15 06:00 PM
Vinnakota RajivDirectorSep 13Sale46.762,213103,48722,969Sep 15 06:00 PM
Trerotola Matthew L.President & CEOSep 13Sale46.6659,5632,779,031305,708Sep 15 06:00 PM
Trerotola Matthew L.President & CEOAug 16Option Exercise23.89151,4463,618,175457,154Aug 18 06:00 PM
Trerotola Matthew L.President & CEOAug 16Sale49.01151,4467,422,924305,708Aug 18 06:00 PM
RALES MITCHELL PDirectorAug 04Buy46.3362,5002,895,8361,170,201Aug 04 06:16 PM
RALES MITCHELL PDirectorAug 03Buy46.6262,5002,913,4871,107,701Aug 04 06:16 PM
RALES MITCHELL PDirectorAug 02Buy45.862009,17214,450Aug 04 06:16 PM
RALES MITCHELL PDirectorAug 02Buy45.90125,0005,737,5001,045,201Aug 04 06:16 PM
Trerotola Matthew L.President & CEOJul 19Option Exercise23.7475,0001,780,500380,708Jul 21 06:00 PM
Trerotola Matthew L.President & CEOJul 19Sale42.6875,0003,201,091305,708Jul 21 06:00 PM
Trerotola Matthew L.President & CEOJun 21Option Exercise23.7475,0001,780,500380,708Jun 23 07:00 PM
Trerotola Matthew L.President & CEOJun 21Sale44.4175,0003,330,450305,708Jun 23 07:00 PM
Hix Christopher MEVP, Chief Financial OfficerJun 14Option Exercise26.5690,0002,390,400182,800Jun 15 09:00 PM
Hix Christopher MEVP, Chief Financial OfficerJun 14Sale45.8990,0004,130,08592,800Jun 15 09:00 PM
Trerotola Matthew L.President & CEOMay 14Option Exercise23.74200,0004,748,000505,708May 17 08:00 PM
Trerotola Matthew L.President & CEOMay 14Sale43.14200,0008,628,400305,708May 17 08:00 PM
Lang Patricia ASVP, Chief HR OfficerMay 03Option Exercise26.8824,677663,31843,218May 04 08:00 PM
Lang Patricia ASVP, Chief HR OfficerMay 03Sale43.9424,6771,084,30718,541May 04 08:00 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Mar 10Sale47.7336,0621,721,290164,257Mar 11 09:00 PM
Kambeyanda ShyamESAB President and EVP, ColfaxMar 10Sale46.7411,897556,06692,545Mar 11 09:00 PM
Hix Christopher MEVP, Chief Financial OfficerMar 10Sale46.7418,206850,94892,800Mar 11 09:00 PM
Tandy Bradley JSVP, General CounselFeb 26Sale44.993,536159,08510,619Mar 01 09:01 PM
Kambeyanda ShyamESAB President and EVP, ColfaxFeb 25Sale46.011,85085,11862,389Feb 26 09:01 PM
Trerotola Matthew L.President & CEOFeb 25Sale46.016,057278,683233,699Feb 26 09:00 PM
Lang Patricia ASVP, Chief HR OfficerFeb 25Sale46.0150723,3279,249Feb 26 09:01 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Feb 25Sale46.011,96190,226101,859Feb 26 09:01 PM
Tandy Bradley JSVP, General CounselFeb 25Sale46.0181537,49814,155Feb 26 09:00 PM
Hix Christopher MEVP, Chief Financial OfficerFeb 25Sale46.012,00792,34269,955Feb 26 09:00 PM
Trerotola Matthew L.President & CEOJan 05Sale38.1222,039840,181200,967Jan 07 07:00 PM
Kambeyanda ShyamESAB President and EVP, ColfaxDec 14Sale37.412,35788,17554,855Dec 15 08:00 PM
Hix Christopher MEVP, Chief Financial OfficerDec 14Sale37.414,483167,70959,449Dec 15 08:00 PM